Primary |
Drug Use For Unknown Indication |
42.9% |
Analgesic Therapy |
28.6% |
Arthritis |
14.3% |
Inflammation |
14.3% |
|
Paralysis |
28.6% |
Death |
14.3% |
Pain |
14.3% |
Product Substitution Issue |
14.3% |
Tubulointerstitial Nephritis |
14.3% |
Vomiting |
14.3% |
|
Secondary |
Drug Use For Unknown Indication |
33.3% |
Headache |
33.3% |
Pain |
16.7% |
Hypotonia |
8.3% |
Inflammation |
8.3% |
|
Drug Hypersensitivity |
64.3% |
Anaphylactic Reaction |
7.1% |
Dysphagia |
7.1% |
Rash |
7.1% |
Skin Lesion |
7.1% |
Tremor |
7.1% |
|
Concomitant |
Product Used For Unknown Indication |
22.4% |
Contraception |
7.5% |
Pain |
7.3% |
Acne |
6.9% |
Drug Use For Unknown Indication |
6.4% |
Hypertension |
6.2% |
Premenstrual Syndrome |
5.6% |
Bronchitis |
4.5% |
Dysmenorrhoea |
3.7% |
Oral Contraception |
3.7% |
Migraine |
3.4% |
Hepatitis C |
3.2% |
Menstruation Irregular |
3.2% |
Anxiety |
2.6% |
Depression |
2.6% |
Multiple Myeloma |
2.2% |
Ovarian Cyst |
2.2% |
Sinobronchitis |
2.2% |
Menorrhagia |
2.1% |
Multiple Sclerosis |
2.1% |
|
Pulmonary Embolism |
15.0% |
Weight Decreased |
11.5% |
Vision Blurred |
8.0% |
Pain |
6.2% |
Tricuspid Valve Incompetence |
5.3% |
Wound Infection |
5.3% |
Xerosis |
5.3% |
Anxiety |
4.4% |
Cholecystitis Chronic |
4.4% |
Cholelithiasis |
3.5% |
Nausea |
3.5% |
Rash |
3.5% |
Septic Shock |
3.5% |
Splenic Infarction |
3.5% |
Vomiting |
3.5% |
Cardiac Disorder |
2.7% |
Deep Vein Thrombosis |
2.7% |
Iud Migration |
2.7% |
Pain In Extremity |
2.7% |
Thrombophlebitis Superficial |
2.7% |
|